TABLE 1.
Weekly Docetaxel and Cisplatin (n = 16) |
Every 3 wk Docetaxel and Cisplatin (n = 11) |
|
---|---|---|
Median age, yr (range) | 64 (47–71) | 63 (42–71) |
Women, no. (%) | 8 (50) | 6 (55) |
Karnofsky performance status, no. (%) | ||
80% | 1 (6) | 5 (45) |
90% | 15 (94) | 6 (55) |
Type of surgery, no. (%) | ||
Lobectomy | 15 (94) | 9 (82) |
Pneumonectomy | 1 (6) | 1 (9) |
Wedge resection | 0 | 1 (9) |
Stage, no. (%) | ||
IB | 5 (31) | 2 (18) |
IIA | 3 (19) | 2 (18) |
IIB | 1 (6) | 4 (37) |
IIIA | 5 (31) | 1 (9) |
IIIB | 2 (13) | 2 (18) |
Histology, no. (%) | ||
Adenocarcinoma | 8 (50) | 8 (73) |
Squamous carcinoma | 2 (13) | 2 (18) |
Adenosquamous | 3 (19) | 1 (9) |
Large cell | 1 (6) | 0 |
Poorly differentiated | 1 (6) | 0 |
Bronchioloalveolar | 1 (6) | 0 |
Days from surgery to 1st chemotherapy (range) | 50 (22–55) | 50 (40–79) |